Page last updated: 2024-09-05

tbc-11251 and natriuretic peptide, brain

tbc-11251 has been researched along with natriuretic peptide, brain in 2 studies

Compound Research Comparison

Studies (tbc-11251)	Trials (tbc-11251)	Recent Studies (post-2010) (tbc-11251)	Studies (natriuretic peptide, brain)	Trials (natriuretic peptide, brain)	Recent Studies (post-2010) (natriuretic peptide, brain)
167	32	58	16,317	1,867	8,887

Protein Interaction Comparison

Protein	Taxonomy	tbc-11251 (IC50)	natriuretic peptide, brain (IC50)
Atrial natriuretic peptide receptor 1	Homo sapiens (human)		0.006

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Safdar, Z	1
Guzik, T; Kopeć, G; Mikołajczyk, T; Miszalski-Jamka, T; Podolec, P; Tyrka, A; Waligóra, M	1

Trials

1 trial(s) available for tbc-11251 and natriuretic peptide, brain

Article	Year
Changes in exercise capacity and cardiac performance in a series of patients with Eisenmenger's syndrome transitioned from selective to dual endothelin receptor antagonist. Heart, lung & circulation, 2012, Volume: 21, Issue:11 Topics: Adult; Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Endothelin-1; Exercise; Female; Follow-Up Studies; Humans; Isoxazoles; Magnetic Resonance Imaging; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Stroke Volume; Sulfonamides; Thiophenes	2012

Article

Year

Changes in exercise capacity and cardiac performance in a series of patients with Eisenmenger's syndrome transitioned from selective to dual endothelin receptor antagonist.

Heart, lung & circulation, 2012, Volume: 21, Issue:11

Topics: Adult; Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Endothelin-1; Exercise; Female; Follow-Up Studies; Humans; Isoxazoles; Magnetic Resonance Imaging; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Stroke Volume; Sulfonamides; Thiophenes

2012

Other Studies

1 other study(ies) available for tbc-11251 and natriuretic peptide, brain

Article	Year
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension. Vascular health and risk management, 2011, Volume: 7 Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Substitution; Dyspnea; Edema; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Liver Function Tests; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen; Phenylpropionates; Pyridazines; Retrospective Studies; Texas; Thiophenes; Time Factors; Treatment Outcome; Walking	2011

Article

Year

Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension.

Vascular health and risk management, 2011, Volume: 7

Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Substitution; Dyspnea; Edema; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Liver Function Tests; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen; Phenylpropionates; Pyridazines; Retrospective Studies; Texas; Thiophenes; Time Factors; Treatment Outcome; Walking

2011